Submission of Matters to a Vote of Security Holders

Business Context and Reporting Period

This Form 8-K is a current report filed by RYVYL Inc. (trading symbol: RVYL) on December 11, 2025. The filing covers events occurring on December 11, 2025, and December 15, 2025, specifically the results of the Company's 2025 Annual Meeting of Stockholders and a notification from the Nasdaq Stock Market regarding listing compliance.

Key Financial Metrics

The filing does not provide specific revenue, profit, cash flow, or debt figures. However, it discloses the following capital structure and equity data as of the record date (October 31, 2025):

  • Common Stock Outstanding: 36,085,978 shares.
  • Series C Convertible Preferred Stock Outstanding: 50,000 shares.
  • Stockholders' Equity: The Company states it believes it has received sufficient capital to meet the $2,500,000 minimum stockholders' equity requirement for continued listing, though it does not meet the $5,000,000 initial listing requirement.
  • Minimum Bid Price: The stock failed to maintain the $1.00 minimum bid price for 30 consecutive business days.

Material Changes and Corporate Actions

Significant corporate actions were approved by stockholders at the Annual Meeting held on December 15, 2025:

  • Reverse Stock Split Authorization: Stockholders approved a reverse stock split of Common Stock at a ratio between 1-for-20 and 1-for-50, to be determined by the Board and implemented no later than June 30, 2026.
  • Authorized Share Increase: Stockholders approved an amendment to increase authorized Common Stock from 100,000,000 to 500,000,000 shares.
  • Director Elections: Four nominees (George Oliva, Brett Moyer, Gene Jones, and Tod Browndorf) were elected to the Board of Directors.
  • Auditor Ratification: Simon & Edward, LLP was ratified as the independent registered public accounting firm.

Outlook, Risks, and Contingencies

Nasdaq Delisting Risk: On December 11, 2025, the Company received a notice from Nasdaq stating it had not regained compliance with the Minimum Bid Price Rule by the December 9, 2025 deadline. Consequently, the Company is not eligible for a second 180-day extension. Unless an appeal is successful, the Common Stock faces delisting from the Nasdaq Capital Market on December 22, 2025.

Remediation Plan: The Company has filed an appeal with the Nasdaq Hearings Panel to stay the delisting. Management intends to effectuate the approved Reverse Stock Split to address the bid price deficiency and expects to regain compliance in the coming weeks.

Risks: There are no assurances that the Company will regain compliance with Nasdaq listing standards, that the Panel will grant an extension, or that the Reverse Stock Split will successfully resolve the bid price issue. Actual results may differ materially from forward-looking statements regarding these outcomes.

Investor Verification Checklist

  • Verify the status of the Nasdaq appeal and the hearing date with the Nasdaq Hearings Panel.
  • Confirm the specific reverse stock split ratio and implementation date once announced by the Board.
  • Review the Company's most recent financial statements to verify the $2,500,000 stockholders' equity claim.
  • Monitor the stock's bid price performance post-announcement to assess immediate market reaction.
  • Check for any subsequent filings regarding the outcome of the Nasdaq appeal before the December 22, 2025 potential delisting date.
Disclaimer:
This AI-generated summary by MetaQuotes is based on SEC filings and may contain errors. Verify important details against the original SEC filings.